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ORIGINAL ARTICLE VIROLOGYComprehensive analysis of mutations in the hepatitis delta virus genome
based on full-length sequencing in a nationwide cohort study and
evolutionary pattern during disease progressionE. Shirvani-Dastgerdi1, S. Amini-Bavil-Olyaee2, S. Moayed Alavian3, C. Trautwein1 and F. Tacke1
1) Department of Medicine III, RWTH-University Hospital Aachen, Aachen, Germany, 2) Department of Molecular Microbiology and Immunology, Keck School of
Medicine, University of Southern California, Harlyne J. Norris Cancer Research Tower, Los Angeles, CA, USA and 3) Baqiyatallah Research Centre for
Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IranAbstractDelta hepatitis, caused by co-infection or super-infection of hepatitis D virus (HDV) in hepatitis B virus (HBV) -infected patients, is the most
severe form of chronic hepatitis, often progressing to liver cirrhosis and liver failure. Although 15 million individuals are affected worldwide,
molecular data on the HDV genome and its proteins, small and large delta antigen (S-/L-HDAg), are limited. We therefore conducted a
nationwide study in HBV-HDV-infected patients from Iran and successfully ampliﬁed 38 HDV full genomes and 44 L-HDAg sequences
from 34 individuals. Phylogenetic analyses of full-length HDV and L-HDAg isolates revealed that all strains clustered with genotype 1 and
showed high genotypic distances to HDV genotypes 2 to 8, with a maximal distance to genotype 3. Longitudinal analyses in individual
patients indicated a reverse evolutionary trend, especially in L-HDAg amino acid composition, over time. Besides multiple sequence
variations in the hypervariable region of HDV, nucleotide substitutions preferentially occurred in the stabilizing P4 domain of the HDV
ribozyme. A high rate of single amino acid changes was detected in structural parts of L-HDAg, whereas its post-translational
modiﬁcation sites were highly conserved. Interestingly, several non-synonymous mutations were positively selected that affected
immunogenic epitopes of L-HDAg towards CD8 T-cell- and B-cell-driven immune responses. Hence, our comprehensive molecular
analysis comprising a nationwide cohort revealed phylogenetic relationships and provided insight into viral evolution within individual
hosts. Moreover, preferential areas of frequent mutations in the HDV ribozyme and antigen protein were determined in this study.
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E-mail: frank.tacke@gmx.netIntroductionHepatitis delta virus (HDV) is a defective virus with a covalently
closed circular single-stranded RNA genome that is the only
member of Deltavirus genus [1]. HDV infection is strictly asso-
ciated with hepatitis B virus (HBV) to obtain its envelope fromMicrobiol Infect 2015; 21: 510.e11–510.e23
nical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2014.12.008hepatitis B surface proteins (HBsAg). The viral genome size is
about 1.7 kb, which encodes two proteins designated as HDV
small D antigen (S-HDAg) and HDV large D antigen (L-HDAg)
[1–3]. Once HDV enters the cell, its genomic RNA is tran-
scribed into intermediate anti-genomic RNA by cellular tran-
scription enzymes [2,3]. Both genomic and anti-genomic
strands have three different regions, including hypervariable,
autocatalytic and HDAg coding domains. Considering non-
conserved sequences of the hypervariable region and the
well-preserved structure of the catalytic domain [4], in-
vestigators agreed to deﬁne HDV genotypes by comparing
HDAg coding domains. However, the best evolutionaryious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Shirvani-Dastgerdi et al. Mutations in HDV genome 510.e12information (reference standard) for HDV is obtained by full-
length genome sequence analyses [5–7]. Phylogenetically,
eight different clades of HDV have been introduced (genotypes
1 to 8) from different parts of the world, with distinct
geographical regions and different outcome of diseases [8].
Globally, more than 15 million people have been co-infected
with HBV and HDV [9]. Due to global HBV vaccination pro-
grammes since the 1990s, HDV infection has been relatively well
controlled in Europe, especially Western Europe [1]. In contrast,
several countries in the Middle East are considered endemic re-
gions for HDV infections [9–13]. Despite partial or full genome
analyses of HDV reported from distinct geographical areas
[14,15], there are limited data available on themolecular evolution
of HDV from this region, particularly Iran [9,16–19]. In the cur-
rent cross-sectional and longitudinal study, we analysed the full-
length genome as well as the entire HDAg coding sequence of
HDV isolates from a large set of HDV antibody positive patients
(n = 34) from different parts of Iran. These analyses aimed to
investigate themolecular epidemiology ofHDV full-length genome
sequences and their evolutionary pattern in a large cohort.Materials and methodsPatients
Seventy-one serum samples from 49 Iranian patients with
chronic HBV-HDV co-infection, who were referred to Tehran
Hepatitis Centre, were included in this study. HBsAg-positive
and HBeAg-negative patients with positive IgG for HDAg were
consecutively included. The Tehran Hepatitis Centre physician
team prepared a questionnaire and recorded available risk
factors, virological, clinical, histological and serological data.
Written informed consent was obtained from all participants,
and the ethics committees of the Baqiyatallah Research Centre
for Gastroenterology and Liver Diseases (Iran) and the RWTH
University Hospital Aachen (Germany) approved the study. All
patients tested negative for hepatitis C virus (HCV) and human
immunodeﬁciency virus (HIV) antibodies.
HDV genome sequencing
HDV RNA was extracted from sera by the QIAamp viral RNA
mini kit (Qiagen, Hilden, Germany) and then subjected to
cDNA synthesis using a Transcriptor First Strand cDNA Syn-
thesis Kit (Roche, Mannheim, Germany), followed by HDV
whole genome ampliﬁcation through a nested-PCR method as
described previously [20]. Amplicons were puriﬁed using the
QIAquick PCR puriﬁcation kit (Qiagen) and subjected to bidi-
rectional primer-walking sequencing using the 3730XL DNA
Analyzer (Applied Biosystems, Foster City, CA, USA).Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfeEvolutionary and phylogenetic analysis
All sequenced fragments were assembled using the CONTIG
ASSEMBLY PROGRAM of the BIOEDIT SEQUENCE ALIGNMENT EDITOR,
version 7.2.0 [21]. To investigate the mutational pattern of
the HDV ribozyme domain and L-HDAg amino acids, the
sequences were compared with each other and with the
same domains of other genotypes of HDV [20]. To perform
the evolutionary and phylogenetic analysis, multiple sequence
alignments were carried out for the assembled full-length as
well as L-HDAg encoding sequences together with deﬁned
HDV genotypes 1 to 8 as reference genes using the MEGA
software, version 5.2 [22]. The Kimura two-parameter algo-
rithm was used to compute evolutionary distances using
MEGA software [23]. Phylogenetic relationships, and evolu-
tionary rates were also calculated with the neighbour-joining
method using 1000 replicate bootstrap value by MEGA
software and conﬁrmed by maximum likelihood analysis
[23,24].
Selective pressure analysis
The numbers of non-synonymous and synonymous sub-
stitutions per site (dN and dS, respectively) for each codon
were estimated to investigate the impact of selective pressure
on the protein. All studied cases were aligned based on their
nucleotide sequences and applied for selection analysis by
VARPLOT software (http://sray.med.som.jhmi.edu/SCRoftware/
VarPlot/) as described elsewhere [25]. The Nei–Gojobori
method was used for the dN/dS calculations. A dN/dS ratio of 1
is indicative of the same levels of synonymous and non-
synonymous mutations at each position, which leads to the
lack of selective pressure at these sites known as neutral evo-
lution. The ratios of dN/dS >1 indicate a ﬁtness advantage of
non-synonymous changes and therefore a positive selection and
for dN/dS <1 a negative selection is expected due to the
detrimental effect of non-synonymous mutations at those sites
[25,26].
Reference numbers of HDV sequences
HDV genotype reference sequences retrieved from GenBank
were genotype 1: AY633627.1_Iran, U81989.1_Ethiopia,
X04451.1_Italy, M84917.1_Lebanon, M58629.1_Nauru,
U81988.1_Somali, M92448.1_Taiwan, D01075.1_US1, and
L22066.1_US2; genotype 2: AB088679.1_Japan; genotype 3:
L22063.1_Peru; genotype 4: AF018077.1_Taiwan; genotype 5:
AX741149.1_dFr47; genotype 6: JA417561.1_dFr48; genotype
7: JA417541.1_dFr45; and genotype 8: JA417566.1_dFr644.
Sequences of the studied isolates were submitted to GenBank
and are available under Accession numbers KJ744214 to
KJ744257.ctious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 510.e11–510.e23
510.e13 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMIResultsPhylogenetic analysis of nationwide full-length HDV
and L-HDAg isolates revealed a single genotype, close
ancestry and limited genetic diversity
Seventy-one serum samples from patients with chronic HBV
infection who were attending the clinic regularly and were
HBsAg positive (more than 6 months), HBeAg negative and
anti-HDAg (IgG) positive were included in this study. Patients
were either receiving no treatment or interferon (for 1 year),
lamivudine and adefovir, alone or in combination. Among the
enrolled samples, ﬁve were negative by PCR analysis, and 22
samples could be ampliﬁed for only small portions of the HDV
genome, which were excluded from the analysis. Hence, 34
patients were available for the cross-sectional study cohort.
Demographic, clinical, serological, virological and biochemical
data of these patients are shown in Table 1. The mean age of
the patients was 42.39 years (ranging from 12 to 67 years), and
73.5% of the participants were male. Among all patients, 64.7%
were diagnosed with liver cirrhosis. Progression to cirrhosis
was deﬁned by liver histology and clinical parameters including
platelet count <100 000 per mm3, features of surface nodularity
by ultrasound, splenomegaly, prolonged prothrombin time,
ascites and/or oesophageal varices by upper gastrointestinalTABLE 1. Demographic, clinical, virological, serological and bioche
Sample code Sex Age ALT (IU/L) Disease status HBV viral load
D1 F 27 56 chronic undetectable
D2-A M 67 131 cirrhosis undetectable
D5-A* F 40 53 cirrhosis 3.1 × 105
D7-A M 20 62 chronic undetectable
D8 F 30 96 cirrhosis undetectable
D9-A M 55 55 cirrhosis undetectable
D10-A F 49 69 cirrhosis 1.1 × 103
D13 M 57 51 cirrhosis 4.7 × 105
D15 M 34 34 chronic 5.9 × 105
D17 F 46 86 cirrhosis 2.9 × 104
D18 M 47 76 cirrhosis undetectable
D21 F 45 95 cirrhosis undetectable
D23 M 63 65 cirrhosis 3.7 × 104
D24 M ND ND ND ND
D26 M 41 46 chronic undetectable
D27 M 33 92 chronic undetectable
D28 M 40 54 cirrhosis undetectable
D29 M 28 82 cirrhosis undetectable
D32 M 47 73 cirrhosis undetectable
D33 M 36 ND chronic ND
D34 M 52 77 cirrhosis 5.9 × 105
D37-A M 50 42 chronic undetectable
D39-A* M 12 68 chronic undetectable
D43† M 44 90 cirrhosis undetectable
D49† M 51 156 cirrhosis 5.0 × 103
D51 M 48 80 chronic undetectable
D52 M 36 71 chronic undetectable
D55 F 51 63 cirrhosis undetectable
D58 M 56 104 cirrhosis undetectable
D60 F 46 110 cirrhosis undetectable
D64 M 39 82 cirrhosis undetectable
D66 M 24 222 chronic undetectable
D69 M 44 67 cirrhosis 2.34 × 104
D70 F 41 21 cirrhosis 1.08 × 102
Notes: ALT upper normal limit = 49 IU/L.
* and † after the sample codes indicate familial relationships: *a mother (D5) and her son (D
Abbreviations: ALT, alanine aminotransferase; F, female; M, male; ND, not determined; LAM
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectendoscopy. Among the 34 studied cases, ten follow-up samples
were available for longitudinal analyses in seven patients.
Consensus sequences of the full-length HDV genome were
obtained from 38 samples following primer-walking and bi-
directional sequencing of puriﬁed PCR products from six
overlapped segments. For six additional samples, consensus
sequence information of the encoding L-HDAg region was
determined. The full-length HDV isolates ranged from 1672 to
1682 nucleotides. Phylogenetic analyses of the 38 HDV full-
length genome sequences (Fig. 1a) as well as the 44 L-HDAg
nucleotide samples (Fig. 1b) revealed that the Iranian HDV
isolates clustered with reference sequences of genotype 1 of
HDV. Based on the clustering and distribution of the isolates,
Iranian strains showed a widespread similarity to HDV geno-
type 1 isolates from East Asian countries (Taiwan, China and
Japan), the Middle East (Iran and Turkey), Europe (Italy) and
USA. Interestingly, there was little relationship with genotype
1 of HDV isolates from African roots (Ethiopia and Somalia).
Phylogenetic tree topology showed that the African lineages
diverged before the diversiﬁcation of the other non-African
HDV genotype 1 lineages (supported by the highest boot-
strap value), indicating that the African isolates might be the
basal lineage that diverged earlier from other genotype 1 of
HDV.mical data of the studied patients co-infected with HBV-HDV
(copies/mL) Risk factor(s) Treatment
family case, tattoo LAM
sexual contact, travelling abroad LAM+ADV
family case LAM
family case IFN




shared razor in prison, sexual contact LAM
family case LAM
warﬁeld injury, blood transfusion, dental surgery LAM+ADV




family case, dental surgery, hospitalization no treatment
family case, tattoo no treatment
family case, dental surgery no treatment
family case no treatment
ND ND
family case IFN
family case no treatment
family case LAM
family case LAM
family case no treatment
family case, dental surgery no treatment
family case, dental surgery LAM
family case no treatment
blood transfusion LAM
family case no treatment
major surgery IFN+LAM




, lamivudine; ADV, adefovir; IFN, interferon.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 510.e11–510.e23
FIG. 1. Phylogenetic analysis of Iranian hepatitis D virus (HDV) isolates based on full genome (a) and large delta antigen (L-HDAg) (b) sequences. The
branches represented in these trees are also supported by maximum likelihood analysis (data not shown). Colours represent geographic distribution of
the samples, which were collected from different areas of the country. Bootstrap values above 70% are indicated at the branch nodes.
CMI Shirvani-Dastgerdi et al. Mutations in HDV genome 510.e14Interestingly, phylogenetic tree analyses of the HDV full-
length genome revealed a clade of three cases (D32, D33 and
D34), which are separated from the other Iranian HDV isolates.
Geographically, these samples belong to a province located in
southeast Iran called ‘Sistan and Baluchistan’, which shares a
common border with Pakistan and Afghanistan. These isolates
had a close relation to African strains, and phylogenetic tree
topology indicated that these strains (D32, D33 and D34) might
be the basal lineage that diverged earlier from the other Iranian
HDV genotype 1. Although people in this region of the country
are considered in close relationship with their relatives from
Afghanistan and Pakistan, phylogenetic trees constructed by the
C-terminal of L-HDAg, either from nucleotides or amino acids,
did not cluster these sequences together with reported HDV
genotype 1 isolates from Pakistan [19] nor from Afghanistan
(data not shown) [16]. This discrepancy may be explained byClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infethe use of a very small portion of HDV genome for evolu-
tionary analysis in these studies.
Accordingly, different samples from the longitudinally stud-
ied cases were grouped together with a high bootstrap value
based on entire genome sequence phylogeny. Next to longi-
tudinal cases, there were a number of intra-familially trans-
mitted cases, which clustered together. For instance, isolates
D43 and D49 were from two brothers and isolates D5 and D39
belonged to a mother and son, respectively.
Importantly, our study included samples from all regions of
the country (depicted in different colours in Fig. 1).
Geographically related isolates include D43/D49/D64 (from
Lorestan province, brown), D5/D10/D39 (from Tehran and
Alborz provinces, black), D23/D27, D21/D24 and D32/D33/
D34 (from Sistan and Baluchistan province, ochre) that clus-
tered together. However, not all samples from onectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 510.e11–510.e23
510.e15 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMIgeographical area shared identical or similar nucleotide content,
indicating a noticeable genetic diversity. For instance, while
isolates D2 and D52 belonged to the same geographical region
in northwest Iran (Azerbaijan province) their phylogenetic
distance obtained from the full-length analysis is higher (12.5%)
than those calculated for D2/D1 (10.3%) and D52/D21, D24
(7%), which were branched together (Fig. 1a). Another example
of this regional genetic diversity is the genetic distance of D43
and D37-B with regard to their L-HDAg fragment analysis. The
phylogenetic distances for D43/D9-A, D43/D9-B and D37-B/
D70, which form branches together (Fig. 1b), are less than the
distance between D43 and D37-B (4%, 3% and 7%, respec-
tively), although both of the latter are from the same geographic
area in west Iran (Lorestan province).
Cross-sectional and longitudinal HDV isolates generally
show a high genotypic distance to HDV genotypes 2–8
The isolates had a mean intra-genotypic distance of 9.6% and
9.9% based on full-length and L-HDAg genome analysis,
respectively (Table 2). They showed minimum mean inter-
genotypic distance with genotype 1 of HDV including isolates
from Italy, China, Ethiopia, Lebanon, Japan, Nauru, Somalia,
Taiwan and USA (mean distances were 10.8% and 11.1% to the
entire genome and L-HDAg sequences, respectively). Based on
full-length genome, the next closest inter-genotypic isolate to
Iranian strains was genotype 2 of HDV with a mean inter-
genotypic distance of 23.9%, followed by genotype 4 with a
mean inter-genotypic distance of 27.0%. The farthermost ge-
notype, as indicated by both types of sequences, was genotype
3 with mean inter-genotypic distances of 41.3% and 39.3%
based on full genome and L-HDAg sequences, respectively
(Table 2).
Genotype distances were also calculated individually for each
investigated isolate based on full-length sequences (Fig. 2a) and
L-HDAg encoding fragments (Fig. 2b). Of note, the isolates D32
and D33 (marked by red circles) had the maximum distances
compared with other Iranian isolates with reported genotype 1
sequences from different countries based on full-length genome
analysis (mean inter-genotypic distance 13.6% and 13.9% versus
10.8%). The same isolates demonstrated matching outcomes
together with D34 for their L-HDAg sequence (distances are
13.9%, 13.7% and 13.0% for D32, D33 and D34 versus 11.1%TABLE 2. Mean inter-genotypic distances ± SD of the Iranian isolate
L-HDAg sequences
Genotype This study 1 2 3
Full-length 9.6 ± 0.5 10.8 ± 1 23.9 ± 0.7 41.3 ± 0.9
L-HDAg 9.9 ± 0.7 11.1 ± 0.9 28.3 ± 1.0 39.3 ± 0.9
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectfor other Iranian isolates, respectively). Moreover, while the
mean intra-group distance value for Iranian isolates was 9.6%,
the inter-group distance between Iranian isolates and D32, D33
and D34 was 12.5%. Of note, these separately branched strains
in the phylogeny tree showed less mean intra-genotypic di-
versity with the genotype 1 HDV isolate from Nauru (12.2%)
and higher mean intra-genotypic diversity with isolates from
Lebanon and Somalia (14.1% and 14.2%, respectively) indicating
close relation with African origins (data not shown).
Longitudinal isolates indicate a reverse evolutionary
trend during the disease
From seven patients, sequential samples were available for a
longitudinal molecular analysis using full-length (n = 13) and L-
HDAg (n = 17) sequences. Clinical and serological data of these
patients at initial sampling and during follow-up are shown in
Table 3. The follow-up duration ranged from 1 month to 4
years. Two patients had cirrhosis when they entered the study
(isolates D9 and D10) and three developed cirrhosis during the
follow-up period (isolates D2, D5 and D39). Among the ﬁve
available follow-up cases with full genome sequence data (Fig. 1,
follow-up samples are indicated by capital letters), three
showed a backward shift in the second sampling (D2, D7 and
D37). The two cases with evolved genomes were isolates D9
(1-year follow up) and D10 (1-month follow up). Phylogenetic
relationships of the L-HDAg nucleotide sequences from seven
longitudinal samples showed reverse evolution in ﬁve isolates
(D2, D5, D7, D9 and D37). However, two isolates, D10 and
D39, as well as the second follow-up sequence of D7 had
evolved compared with the primary sequence. Both of the
isolates D7-B and D10 were 1-month follow-up samples, which
shows that HDV genome and its protein-coding domain are
constantly changing at a high rate.
Isolate D39 was from a young HBV-HDV co-infected boy (12
years old at the ﬁrst sampling time), whose mother was also
enrolled in the study (isolate D5). L-HDAg amino acids of
isolate D39 (son) contained more mutations compared with
that of D5 (mother), after 4 years of follow up (Fig. 3a) with
96.7% similarity rate for D39 and 98.1% for D5 (Fig. 3b).
Moreover, there was only 89.2% similarity between the two
samples, D5 and D39 at the baseline. Assuming that the son had
been infected by the same isolates as the mother at birth, theses and genotypes 1 to 8 of HDV based on full-length genome and
4 5 6 7 8
27.0 ± 0.8 28.4 ± 0.8 30.2 ± 0.9 31.5 ± 1.0 30.6 ± 0.9
25.5 ± 1.0 29.6 ± 1.0 29.1 ± 0.9 31.4 ± 1.0 30.8 ± 1.0
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 510.e11–510.e23
FIG. 2. Inter-genotypic distances are displayed based on hepatitis D
virus (HDV) full-length (a) and large delta antigen (L-HDAg) genome (b)
sequences. Iranian samples with highest distances to reference HDV
genotype (GT) 1 are marked by circles (isolates D32, D33 and D34).
CMI Shirvani-Dastgerdi et al. Mutations in HDV genome 510.e16variations may indicate distinct selection forces on the HDV
genome related to the host on the one hand and the effect of
age on viral dynamics and evolution on the other. Moreover, it
is remarkable that both cases developed cirrhosis during their
4-year observation period (Table 3). Although this clinical sta-
tus might be expected for the mother regarding her age (40
years) and long period of viral infection, the persistent increase
in alanine aminotransferase (ALT) levels of the son and devel-








D2 B 1 year 105 No treatment LAM+ADV Chronic
C 2 year 247 Cirrhosis
D5 B 4 year 34 No treatment LAM Cirrhosisa
D7 B 1 month 19 No treatment IFN Chronic
C 8 months 42 Chronic
D 16 months 71 Chronic
D9 B 1 year 95 IFN LAM+ADV Cirrhosis
D10 B 1 month 75 No treatment ADV Cirrhosis
D37 B 6 months 48 IFN No treatment Chronic
D39 B 4 years 155 No treatment LAM Cirrhosisa
The time intervals are indicated with reference to the ﬁrst sampling. Treatments of
the patients at the last sampling time (current) and before that (history), are
indicated.
Abbreviations: ADV, adefovir; ALT, alanine aminotransferase; IFN, interferon; LAM,
lamivudine.
aPatients developed cirrhosis during their follow up.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infeto the special amino acid substitutions at his L-HDAg domain
(Fig. 3). Interestingly, the son displayed persistent (though
ﬂuctuating) signs of liver injury (during 4 years, ALT levels were
68, 120, 108 and 155 IU/L, respectively), whereas the mother
showed a rather low and overall declining level of ALT during
this time (during 4 years, ALT levels were 53, 51, 46 and 34 IU/
L, respectively). The correlation between these mutations and
disease progression and/or immune-mediated responses,
however, requires further studies.
Nucleotide substitutions preferentially occur in the
stabilizing P4 domain of the HDV ribozyme
In order to estimate the potential functional consequences of
sequence alterations of HDV isolates, self-cleavage sites of HDV
genomic and anti-genomic strands were compared for their
nucleotide composition. The nucleotide logo of the aligned se-
quences was constructed [27] and the pseudoknot secondary
structures were obtained from www.rnasoft.ca. Results of HDV
catalytic domain analysis and secondary structures represented by
themajority of sequences are shown in Fig. 4a and 4b, respectively.
Both RNAs form pairings (P1, 2, 3 and 4) as well as loop (L3) and
single-stranded (J1/2, J1/4 and J4/2) structures in their secondary
forms (Fig. 4b) [28]. The most conserved domain in both RNAs of
the studied samples was the P3 domain. Anti-genomic ribozyme
domains showed a conserved sequence in P1, J1/2, P2 and J1/4, and
genomic RNA harboured only one substitution in each of these
domains (Fig. 4a). On both genomic and anti-genomic strands,
mutations mainly occurred at the P4 domain of the catalytic area
(68% and 95% for genomic and anti-genomic strands, respectively,
Fig. 4b). In addition to base substitutions at this region, there was
one pyrimidine insertion between C67 and U68 in the P4 domain
of anti-genomic RNA (numbering starts from the cutting site). Base
deletions were also detected in C64 of genomic and C59 of anti-
genomic strands (in seven and twelve isolates, respectively). P4
has been found to act as a conformational stabilizer since a com-
plete deletion of this part does not inhibit ribozyme activity [29].
Besides the P4 mutations, some other mutations occurred at
different positions of both genomic and anti-genomic strands.
Mutational pattern analyses revealed that after P4 region, L3
with nine mutations and J4/2 with six mutations on both strands
at the ribozyme domains had the highest frequency of muta-
tions (Table 4).
High rate of single amino acid mutations in structural
parts of L-HDAg is associated with positive selection of
mutations at immunogenic epitopes of L-HDAg, while
post-translational modiﬁcation sites are highly
conserved in HDV isolates
We next performed an L-HDAg amino acid sequence alignment
of all 44 isolates as well as a synonymous and non-synonymousctious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 510.e11–510.e23
FIG. 3. Hepatitis D virus (HDV) isolates sampled simultaneously during a 4-year follow up of an HDV-infected mother (D5) and her son (D39). (a)
Large delta antigen (L-HDAg) amino acid alignment of the isolates. (b) Schematic L-HDAg amino acid similarities at initial sampling and after 4 years are
depicted.
510.e17 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMImutation analysis of the L-HDAg nucleotides in which dN/dS >1
indicated an overabundance of non-synonymous substitutions
at each site (Fig. 5a,b). No deletions or insertions were
observed among the sequences. Although HDAg protein bears
more amino acid changes compared with structural proteins of
other RNA viruses [30], functionally important amino acid
positions such as leucine-115, which has been shown to be
necessary for in vitro RNA binding activity and viral replication
[31], showed no variability.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectDifferent RNA binding domains have been suggested for
HDAg, which were all arginine-rich motifs. Nevertheless,
lysine–arginine substitutions occurred regularly in the isolates
from Iranian patients. All residues at the post-translational
modiﬁcation sites were also conserved except for two sub-
stitutions, one serine to glycine exchange at position 2 in the D69
isolate and one arginine to lysine switch at position 13 in the D1
isolate. However, in both cases the superseded residue has the
same characteristics as the main one, hence the role of the aminoious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 510.e11–510.e23
FIG. 4. (a) Hepatitis D virus (HDV) ribozyme logo based on 38 aligned sequences. Cleavage sites and important nucleotides for base pairing to form
secondary structures are shown (asterisks). Note that there is a base insertion after C67 in anti-genomic strands in some sequences, which affects base
numbering onwards. (b) Pseudoknot secondary structure of the ribozyme represented by majority of sequences as well as cleavage sites and
conformational domains are shown. Red asterisks indicate the positions at which mutations occur. The P4 domain is highlighted in red due to the high
frequency of mutations in this region.
CMI Shirvani-Dastgerdi et al. Mutations in HDV genome 510.e18acids might not be impeded by these replacements. There are
also some features of heterogeneity in the packaging signal region
including residues 198 and 202, as deﬁned based on previously
reported sequences from other countries [8,19], whose poten-
tial implications require further functional analyses.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfeMoreover, based on the substitution analysis, on average
10.6% of L-HDAg codons (23 codon sites) were under positive
selection, which was higher than previously reported rates for
non-synonymous changes in the HDAg protein [26,32]. Inter-
estingly, the positively selected codons were located in CD8+ctious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 510.e11–510.e23
TABLE 4. Genomic (G) and anti-genomic (AG) mutations of
HDV ribozyme in 38 studied isolates
Ribozyme mutation G/AG Ribozyme domain Mutation frequency
U9G G J1/2 2.6%
U23C G L3 23.6%
U26C AG L3 2.6%
U37G G P1 2.6%
C41U G J1/4 2.6%
C76G, U AG J4/2 5.2%, 2.6%
G76A G J4/2 7.8%
G82A G P2 2.6%
Due to the high number of mutations in the P4 domain, changes in this area are not
shown.
510.e19 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMIT-cell and immunodominant B-cell epitopes, related to cellular
or humoral antiviral immune responses, respectively [26,33].DiscussionIn this cross-sectional and longitudinal study, we analysed 38
full-length and 44 L-HDAg encoding fragments from 34 Iranian
HBV-HDV co-infected patients. HDV genomes were analysed
for phylogeny, sequence similarities, ribozyme mutational
pattern and selection of mutations over time. Phylogenetic
analysis of the samples positioned all Iranian isolates together
with reported HDV genotype 1 from East Asia (Taiwan, China),
the Middle East (Iran, Turkey), Europe (Italy) and USA, but
separated them from HDV genotype 1 isolates proposed as the
‘African–Middle East’ subgroup that was introduced in 1996
[34]. Distance analysis of the samples, in accordance with
phylogenetic results, also revealed the minimum and maximum
distances with HDV genotypes 1 and 3, respectively. Similar
genotyping results were reported from Iran previously, but
previous studies employed a small portion of the HDV genome
with fewer HDV isolates [11,20,35]. The clustering of Iranian
isolates with genotype 1 reference isolates from different parts
of the world may indicate that the virus has been introduced to
the country from different sources.
In this study, we employed HDV full-length genome and L-
HDAg coding nucleotide sequences to study the phylogenetic
relationship of samples with known genotypes, which allowed a
more accurate and comprehensive analysis of the virus than
comparing HDAg sequences or its C-terminal domain as sug-
gested by other investigators [5]. Phylogenetic analysis of the
samples generally showed that geographically, longitudinally and
familially related isolates tend to form clusters together. Three
of the analysed isolates, D32, D33 and D34, formed a separate
branch with high bootstrap values in full-length and L-HDAg
fragment phylogeny analysis. These cases were from a province
located at the border with Pakistan and Afghanistan, whereClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectHDV infection is prevalent [9,12]. The formation of a potential
subgroup of HDV clade 1 by Pakistani isolates was previously
reported [19]. However, neighbour-joining analysis of our cases
with the reported sequences from these two countries, rep-
resenting the C-terminal domain of the L-HDAg, did not cluster
them together (data not shown) stressing that partial genome
analysis is not sufﬁcient for evolutionary analysis. Distance
analysis of the three branched isolates with worldwide HDV
genotype 1 sequences resulted in a mean intra-genotypic dis-
tance of 13.8% for D32 and D33 isolates based on the entire
genome sequences, and 13.5% for D32, D33 and D34 based on
the L-HDAg fragment, whereas these rates for all isolates were
10.8% and 11.1%, respectively. Considering the diversity in
nucleotide sequence of L-HDAg fragment, which should be less
than 14–15.7% among different isolates of the same genotypes
and 19–38% between genotypes [36], these numbers might be
indicative of emerging quasi-subgroup(s) of HDV in these areas
[6,37,38].
Interestingly, the longitudinal sequences of the full-length
(nine sequences from three patients) and L-HDAg amino
acids (13 sequences from ﬁve patients) demonstrated that some
isolates appear to ‘regress’ towards their original sequence
over time. Although the small number of cases with follow-up
sampling limits our study, a possible explanation for our notion
may be ‘reverse evolution’ as a temporary adaptation to
changes in the host condition [39,40]. In a computational ex-
amination, the slow switch of the environmental situation and
the small size of the affected population have been suggested as
essential elements for such reversal changes [41]. In fact, anti-
viral treatment or host-related alterations may force this pro-
cess in HDV-infected individuals. A more in-depth study with a
higher number of follow-up cases is required to further
investigate this concept.
Because of the rolling circle mechanism that HDV employs
to amplify its genome, the ribozyme activity and RNA cleavage
is crucial to produce unit-length molecules [28,42]. For genome
self-cleavage activity, HDV requires at least 85 nucleotides, of
which 84 are located at the 30 end of the cleavage site on both
genomic and anti-genomic RNAs [43]. It has been suggested
that the P3, L3 and J4/2 domains are important for the active
sites of the ribozyme, while P2 and P4 may harbour mispairing
as well as difference in length due to deletion or insertion [28].
In line with this, our study of genomic and anti-genomic auto-
catalytic domains of the HDV isolates revealed that the majority
of mutations occurred at the P4 region. A high rate of muta-
tions in this region (68% and 95% for genomic and anti-genomic
strands, respectively) agree well with a rather structurally sta-
bilizing role of P4, as proposed by previous studies [44,45].
Consistent with previous reports, the P3 domain was the
most conserved region in both RNAs in all isolates. Studies alsoious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 510.e11–510.e23
FIG. 5. (a) Large delta antigen (L-HDAg) sequence alignment logo based on 44 isolates from hepatitis B virus/hepatitis D virus (HBV-HDV) co-infected
patients. Functional domains (presented by boxes) and post-transcriptional modiﬁcation (PTM) sites (illustrated as circles) are indicated. (b) Sites under
positive selection in L-HDAg of 44 isolates. A value of dN/dS >1 indicates overabundance of non-synonymous mutations at each codon. The highlighted
zone depicts the codons, which are affected by positive selection (codons 136 to 159). Boxes on top of the ﬁgure show the immunogenic epitopes of
the protein. The alteration of amino acids at immunogenic CD8+ T-cell and B-cell epitopes is noteworthy. Abbreviations: RBD, RNA binding domain;
CCD, coiled coil domain; NLS, nuclear localization signal; P, phosphorylation; M, methylation; A, acetylation; I, isoprenylation; BCE, B-cell epitope;
CD8+, CD8+ T-cell epitope; CD4+, CD4+ T-cell epitope.
CMI Shirvani-Dastgerdi et al. Mutations in HDV genome 510.e20indicated that the nucleotides in L3, as a conserved domain, are
either essential for cleavage activity of the ribozyme or
contribute to its optimal activity [44,46]. Conversely, the U23/
26C mutation (numbers are indicated by genomic nucleotideClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infenumber followed by anti-genomic nucleotide number, starting
from the cutting site) was surprisingly frequent (23.6% of the
isolates) in the L3 domain. However, this substitution may be
less relevant on a functional level, because the two ﬁrstctious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 510.e11–510.e23
510.e21 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMInucleotides (U20/23, C21/24) were described as most impor-
tant in this loop [43,44]. In a mutational study, a U23/26A base
transversion of the anti-genomic strand resulted in an about
two-fold reduced activity of the ribozyme, which changed to a
two- to three-fold increase when formamide was applied,
indicating that folding is affected by the mutation [46]. Hence,
the U23/26C base transition that occurred in all studied mu-
tants may not have a severe inﬂuence on ribozyme activity.
We also observed two sets of mutations, which are ex-
pected to drastically reduce ribozyme activity in J4/2 of anti-
genomic and P1 domain of genomic strands (C76G, U and
U37G, respectively) [43,46–48]. Recent in vitro studies showed
that changes in these domains in either of the strands resulted
in severely reduced or complete loss of activity of the enzyme
or a reduced interaction between metal ions and RNA
[42,43,46–49]. Interestingly, follow-up data of the patients with
these mutations showed a reverse change to the wild-type
phenotype after time but HDV replication was not abolished
as one could anticipate from in vitro study [48]. The striking
pattern of these reverting mutations may therefore indicate
reduced ribozyme activity in vivo [50,51].
The role of the J1/2 region is described as a pairing
connector sequence, as it can be deleted entirely in a catalytic
trans-reaction [52]. However, its highly conserved nucleotide
content for anti-genomic RNA, as also shown in this study, may
hint at a more important role for this domain. In the isolates of
our study, we only detected one U9/10G mutation in genomic
RNA in this area. There are also two mutations determined in
J1/4 (C41/43U) and P2 (G82/82A), which might be less
important because of the position and the rather structural
function of these domains [44].
A relatively high variability in the amino acid composition of
the HDAg protein is a common feature in HDV [30], but the
functional consequences of clinically observed amino acid sub-
stitutions in this protein are not fully understood. Although two
arginine-rich motifs are reported to be essential to form pro-
tein complexes with HDV RNA (residues 97 to 107 and 136 to
146) [53], a recent study on the RNA binding activity of HDAg
suggested a predominant role of the N-terminal domain plus a
wide distribution of basic and non-basic residues involved in this
reaction over the whole protein sequence [54]. Our results are
in agreement, indicating a more conserved arginine content of
the protein in amino acids 2 to 27 (N-terminal domain) and 97
to 107, but there are substituted residues in the third suggested
RNA-binding domain (R139E and E141K) [53]. This may point
to a less important role for RNA binding of this domain or
suggest a similar activity of glutamic acid or lysine at these
positions.
Both S-HDAg and L-HDAg proteins harbour some post-
transcriptional modiﬁcations at speciﬁc sites, which are allClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectnecessary for different steps of HDV’s life cycle [2,3]. No
signiﬁcant difference in the amino acid content of L-HDAg
post-translational modiﬁcations was observed among the
isolates except one serine to glycine at position 2 and one
arginine to lysine at position 13. These two sites are
important for HDAg phosphorylation and methylation,
respectively, and are responsible for controlling and regu-
lating HDV genomic or anti-genomic replication. As glycine
and lysine have similar characteristics as serine and arginine,
and besides the lower importance of serine 2 compared with
serine 177 and the ability of methyltransferase to recognize
lysine as a substrate [2,55,56], these substitutions may not
hinder HDAg function. The other amino acid substitutions,
including those in positions 198 and 202, are similar to
already reported residues from other countries; the possible
functional effect on HDAg properties requires further ana-
lyses [8,11,19,20].
Positive selection forces, such as immune responses in the
host, may determine sequence diversity and the mutational
pattern [57,58]. Results obtained from other studies indicated
that the rate of non-synonymous substitutions in HDV is higher
compared with other RNA viruses such as inﬂuenza virus,
hepatitis C virus or retroviruses, because the third position of
the codons is more conserved in HDV [30,59,60]. In a study of
33 HDAg sequences of genotypes 1 to 4, 18 codons were
detected to be under positive selection [32]. In a follow-up
study on ﬁve HBV-HDV co-infected patients 3 years later,
4.9% of the codons were reported to be under positive se-
lection [26]. In our study, 10.6% of the codons (23 residues)
were under diversifying positive selection, which is higher than
anticipated from previous reports. The positively selected do-
mains are located in the cytotoxic T-cell and B-cell epitopes,
both relevant for cellular and humoral adaptive immune re-
sponses, respectively. As other reports about the varying co-
dons of HDAg also referred to the immunogenic domain of
these alterations, these mutations may aid the virus to escape
from the host’s immune response [25,26,32,61].
From a clinical point of view, delta hepatitis is the most se-
vere form of chronic hepatitis, often resulting in rapid liver
disease progression and life-threatening complications [1,2].
This is also reﬂected by the high rate (>50%) of liver cirrhosis in
the patient cohort analysed in this study. To what extent the
molecular alterations observed in our comprehensive and
detailed full-length sequence analysis of HDV isolates impact the
clinical course of liver disease needs to be investigated. This is
especially important for the remarkable ‘reverse evolutionary
trend’ in the longitudinal samples, hinting at a more replicative
and probably more pathogenic virus evolution over time as well
as for the relatively high diversity in the L-HDAg amino acid
sequence in the immunogenic epitopes, which may be relatedious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 510.e11–510.e23
CMI Shirvani-Dastgerdi et al. Mutations in HDV genome 510.e22to viral escape from immune responses and could help to serve
as a starting point for improved therapeutic or vaccine
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